Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX73 Sotorasib
D12055 Sotorasib (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Sotorasib
D12055 Sotorasib (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D12055 Sotorasib (JAN/USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D12055 Sotorasib
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Signaling molecules
G protein
KRAS* [HSA_VAR:3845v1]
D12055 Sotorasib (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12055
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12055
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12055
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D12055
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D12055